ZP4207 + Placebo
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypoglycemia
Conditions
Hypoglycemia
Trial Timeline
Apr 1, 2015 → Aug 1, 2015
NCT ID
NCT02390141About ZP4207 + Placebo
ZP4207 + Placebo is a phase 1 stage product being developed by Zealand Pharma for Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT02390141. Target conditions include Hypoglycemia.
What happened to similar drugs?
2 of 14 similar drugs in Hypoglycemia were approved
Approved (2) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
6
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02390141 | Phase 1 | Completed |
Competing Products
20 competing products in Hypoglycemia